Table 3.
Animal experiments and cell culture studying the causal relationship between TMAO and AS.
Experimental models | Intervention | Main observations | References | |
---|---|---|---|---|
Positive results | C57BL6/J mice | Feeding with choline- or TMAO-enriched diet before transverse aortic constriction | Either TMAO- or choline-enriched diets enhanced heart failure severity | [45] |
ApoE−/− mice Germ-free mice |
Feeding with additional choline | The AS plaque area was increased compared with mice fed with a control diet | [5] | |
Peritoneal macrophages | The mice were fed a diet with TMAO, betaine, or choline | (1) The mRNA levels of CD36 and SR-A1 were increased (2) The macrophages had excess cholesterol accumulation and foam cell formation |
[5] | |
ApoE−/− mice | Redundant L-carnitine or antibiotics were introduced into the diet | TMAO could suppress RCT and levels of liver BA synthetase and BA transporters and modulate the activity of cholesterol transporters in macrophages | [25] | |
LDLR−/− mice | Chronic choline supplementation | Plasma TMAO concentrations were increased and inflammatory gene expression in vascular cells was increased | [90] | |
FeCl3-induced carotid artery injury mice Germ-free mice |
i.p. TMAO or feeding with diet (0.12% TMAO or 1% choline supplementation) | (1) Intestinal flora promoted the conversion of choline to TMAO (2) There was an association of choline, TMAO, and thrombus risk |
[26] | |
Platelets | Platelets were exposed to TMAO | TMAO could enhance platelet activation from multiple agonists by increasing the release of Ca2+ from intracellular stores | ||
LDLR−/− mice ApoE−/− mice Il23−/− mice, Il22−/− mice |
The mice were fed with Western diet | IL-23 and its downstream target IL-22 relieved AS by inhibiting TMAO | [46] | |
ApoE−/− mice/peritoneal macrophages and RAW264.7 | The mice were fed a high-fat diet with or without TMAO for 8 weeks/the cells were treated with TMAO or ox-LDL | (1) TMAO promoted the AS in vivo and in vitro (2) The CD36/MAPK/JNK pathway may play a crucial role in TMAO-induced formation of foam cells |
[51] | |
Mice at 20-24 months of age and mice at 8-10 weeks of age | The mice were treated for 3-4 weeks with broad-spectrum poorly absorbed antibiotics | (1) The gut microbiota was an important mediator of age-related arterial dysfunction (2) Plasma TMAO was higher in aged mice (3) Endothelial dysfunction and oxidative stress were elevated with aging |
[47] | |
| ||||
Negative results | ApoE−/− mice | The mice were supplemented with choline at 8 weeks of age | No association was observed between TMAO and the risk of AS | [48] |
ApoE−/− mice | The mice were transfected with an adeno-associated viral vector containing the human CETP gene | TMAO slowed the aortic lesion formation in ApoE−/− mice | [49] | |
LDLR−/− mice ApoE−/− mice |
Dietary intervention using extra choline, betaine, or TMAO | Dietary choline, betaine, or TMAO supplementation did not induce AS development | [50] |
AS: atherosclerosis; TMAO: trimethylamine N-oxide; ApoE−/−: apolipoprotein E-deficient; RCT: reverse cholesterol transport; BA: bile acids; LDLR−/−: lipoprotein receptor-deficient; ADP: adenosine diphosphate; RAW264.7: a macrophage cell line; ox-LDL: low-density lipoprotein; CD36: cluster of differentiation 36; IL: interleukin; MAPK: mitogen-activated protein kinases; JNK: c-Jun N-terminal kinase; SR-A1: scavenger receptor A1; CETP: cholesteryl ester transfer protein.